rs142030898
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_013254.4(TBK1):c.1330C>T(p.Arg444*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000379 in 1,583,282 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic,other (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_013254.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- frontotemporal dementia and/or amyotrophic lateral sclerosis 4Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
- frontotemporal dementia with motor neuron diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 8Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
- autoinflammation with arthritis and vasculitisInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| TBK1 | NM_013254.4 | c.1330C>T | p.Arg444* | stop_gained | Exon 11 of 21 | ENST00000331710.10 | NP_037386.1 | |
| TBK1 | XM_005268809.2 | c.1330C>T | p.Arg444* | stop_gained | Exon 11 of 21 | XP_005268866.1 | ||
| TBK1 | XM_005268810.2 | c.1330C>T | p.Arg444* | stop_gained | Exon 11 of 21 | XP_005268867.1 | ||
| TBK1 | XR_007063071.1 | n.1429C>T | non_coding_transcript_exon_variant | Exon 11 of 18 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000134 AC: 3AN: 224578 AF XY: 0.0000164 show subpopulations
GnomAD4 exome AF: 0.00000349 AC: 5AN: 1431106Hom.: 0 Cov.: 29 AF XY: 0.00000702 AC XY: 5AN XY: 711966 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338 show subpopulations
ClinVar
Submissions by phenotype
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4 Pathogenic:1
This sequence change creates a premature translational stop signal (p.Arg444*) in the TBK1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TBK1 are known to be pathogenic (PMID: 25803835, 26476236, 26581300). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with amyotrophic lateral sclerosis (PMID: 26804609, 28089114). ClinVar contains an entry for this variant (Variation ID: 266072). Algorithms developed to predict the effect of variants on gene product structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this premature translational stop signal affects TBK1 function (PMID: 26804609). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:1
The R444X nonsense variant in the TBK1 gene has been reported previously in association with ALS with and without FTLD (Black et al., 2017; Tsai et al., 2016). In vitro functional studies shower lower protein expression and loss of kinase activity (Tsai et al., 2016). The R444X variant is predicted to result in nonsense-mediated mRNA decay or protein truncation. In vitro functional studies indicate that the truncated protein lacked kinase activity (Tsai et al., 2016). This variant is not observed in large population cohorts (Lek et al., 2016). Based on the currently available clinical and molecular information, we interpret R444X as a pathogenic variant. -
Motor neuron disease Other:1
Loss-of-function but lacking segregation data Loss-of-function
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at